HomeCompareGFKRF vs JNJ

GFKRF vs JNJ: Dividend Comparison 2026

GFKRF yields 5000.00% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GFKRF wins by $62217131802825.32M in total portfolio value
10 years
GFKRF
GFKRF
● Live price
5000.00%
Share price
$0.04
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$62217131802825.35M
Annual income
$59,861,980,287,378,210,000.00
Full GFKRF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — GFKRF vs JNJ

📍 GFKRF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGFKRFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GFKRF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GFKRF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GFKRF
Annual income on $10K today (after 15% tax)
$425,000.00/yr
After 10yr DRIP, annual income (after tax)
$50,882,683,244,271,480,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, GFKRF beats the other by $50,882,683,244,271,480,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GFKRF + JNJ for your $10,000?

GFKRF: 50%JNJ: 50%
100% JNJ50/50100% GFKRF
Portfolio after 10yr
$31108565901412.69M
Annual income
$29,930,990,143,689,110,000.00/yr
Blended yield
96.21%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

GFKRF
No analyst data
Altman Z
1.5
Piotroski
2/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GFKRF buys
0
JNJ buys
0
No recent congressional trades found for GFKRF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGFKRFJNJ
Forward yield5000.00%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$62217131802825.35M$30.3K
Annual income after 10y$59,861,980,287,378,210,000.00$4,689.40
Total dividends collected$62057786341622.61M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: GFKRF vs JNJ ($10,000, DRIP)

YearGFKRF PortfolioGFKRF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$510,700$500,000.00$10,592$272.30+$500.1KGFKRF
2$24,410,935$23,864,485.98$11,289$357.73+$24.40MGFKRF
3$1,092,192,501$1,066,072,800.30$12,123$472.89+$1092.18MGFKRF
4$45,746,366,951$44,577,720,975.17$13,141$629.86+$45746.35MGFKRF
5$1,793,932,828,410$1,744,984,215,772.56$14,408$846.81+$1793932.81MGFKRF
6$65,871,973,805,320$63,952,465,678,921.49$16,021$1,151.60+$65871973.79MGFKRF
7$2,265,146,887,602,700$2,194,663,875,631,007.20$18,122$1,588.22+$2265146887.58MGFKRF
8$72,954,689,148,998,180$70,530,981,979,263,280.00$20,930$2,228.20+$72954689148.98MGFKRF
9$2,201,076,182,660,884,700$2,123,014,665,271,456,500.00$24,792$3,191.91+$2201076182660.86MGFKRF
10$62,217,131,802,825,350,000$59,861,980,287,378,210,000.00$30,274$4,689.40+$62217131802825.32MGFKRF

GFKRF vs JNJ: Complete Analysis 2026

GFKRFStock

Opus One Gold Corporation engages in the acquisition, exploration, and evaluation of mineral properties primarily in Canada. It explores for gold and base metals. The company holds 100% interests in the Northern Abitibi project that consists of Vezza Extension, Vezza North, and Bachelor Extension properties located in the Abitibi region of Quebec; and the Courville project situated in Courville Township, Quebec. It has an option to acquire 100% interests in the Noyell property situated in the Northern Abitibi Greenstone Belt, Quebec. The company was formerly known as Opus One Resources Inc. and changed its name to Opus One Gold Corporation in October 2020. Opus One Gold Corporation was incorporated in 1979 and is headquartered in Saint-Lambert, Canada.

Full GFKRF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this GFKRF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GFKRF vs SCHDGFKRF vs JEPIGFKRF vs OGFKRF vs KOGFKRF vs MAINGFKRF vs ABBVGFKRF vs MRKGFKRF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.